Literature DB >> 27128703

Harnessing the Power of the Host: Improving Dendritic Cell Vaccines for Malignant Pleural Mesothelioma.

Tobias Peikert1, Daniel H Sterman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27128703     DOI： 10.1164/rccm.201512-2444ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

Review 1.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

Review 2.  Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma.

Authors:  Steven G Gray
Journal:  BMC Pulm Med       Date:  2021-05-05       Impact factor: 3.317

Review 3.  Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives.

Authors:  Steven G Gray; Luciano Mutti
Journal:  Transl Lung Cancer Res       Date:  2020-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.